PharmRight Corporation is a pharmaceutical startup that was founded in 2013 with the goal of enhancing medication adherence and fostering independent living among patients. The company's flagship product is Livi, a cutting-edge, fully-automated home medication dispensing system that leverages cellular communications and cloud-based applications for remote device and data management. Despite being relatively new to the market, PharmRight Corporation has garnered significant attention, having secured a $310.52K investment through a Convertible Note in September 15, 2017. The investment was facilitated by VentureSouth, underscoring the confidence that reputable investors have in the company's vision and capabilities. Operating from the United States, PharmRight Corporation continues to demonstrate potential for growth and impact within the pharmaceutical industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | $310.52K | 1 |
|
15 Sep 2017 |
| Convertible Note | $844.50K | 1 |
|
31 Dec 2016 |
| Convertible Note | $1.25M | 1 |
|
15 Jun 2016 |
| Series A | $2.37M | 5 |
|
15 Oct 2015 |
| Angel Round | $992.00K | - | 09 Dec 2014 |
No recent news or press coverage available for PharmRight Corporation.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
